Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT04988217Phase 1/2Completed
Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
Coronavirus Disease 2019
StudydirectorStart date: 2021-09-15
NCT04186949Completed
Early Origins of Allergy and Asthma
Allergic SensitisationAllergyAsthma+2 more
StudydirectorStart date: 2018-10-09
NCT02046577Phase 2Completed
Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children
Acute Respiratory Tract Infections
Studydirector

Research Network

Collaboration Network

18 collaborators·53 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Harris, M.D.

Pontificia Universidad Catolica de Chile

Similar
1 trials

Shared therapeutic areas:

Allergic SensitisationHypersensitivityAsthma+2 more

Worked with same sponsors:

Comisión Nacional de Investigación Científica y TecnológicaPontificia Universidad Catolica de Chile+1 more
Collaborated on 1 trial
Similarity Score54%

Paola Casanello, PhD

Pontificia Universidad Catolica de Chile

Similar
2 trials

Shared therapeutic areas:

Allergic SensitisationHypersensitivityAsthma+2 more

Worked with same sponsors:

Comisión Nacional de Investigación Científica y TecnológicaPontificia Universidad Catolica de Chile+1 more
Collaborated on 1 trial
Similarity Score54%

José A Castro-Rodriguez, M.D. PhD

Pontificia Universidad Catolica de Chile

Similar
1 trials

Shared therapeutic areas:

Allergic SensitisationHypersensitivityAsthma+2 more

Worked with same sponsors:

Comisión Nacional de Investigación Científica y TecnológicaPontificia Universidad Catolica de Chile+1 more
Collaborated on 1 trial
Similarity Score54%

Catalina Le Roy, M.D.

Pontificia Universidad Catolica de Chile

Related
1 trials

Shared therapeutic areas:

Acute Respiratory Tract Infections

Worked with same sponsors:

Laboratorio PasteurNational Fund for Research and Development in Health, Chile+1 more
Collaborated on 1 trial
Similarity Score14%

Carolina Iturriaga, R.N.

Pontificia Universidad Catolica de Chile

Related
1 trials

Shared therapeutic areas:

COVID-19

Worked with same sponsors:

Altum Pharmaceuticals INCPontificia Universidad Catolica de Chile
Collaborated on 1 trial
Similarity Score14%

Karin Brikmann, M.D.

Hospital Regional de Punta Arenas

Related
1 trials

Shared therapeutic areas:

Acute Respiratory Tract Infections

Worked with same sponsors:

Laboratorio PasteurNational Fund for Research and Development in Health, Chile+1 more
Collaborated on 1 trial
Similarity Score14%

Eleanor Fish, Ph.D.

University Health Network, Toronto, Canada

Related
1 trials

Shared therapeutic areas:

COVID-19

Worked with same sponsors:

Altum Pharmaceuticals INCPontificia Universidad Catolica de Chile
Collaborated on 1 trial
Similarity Score14%

Carolina Loureiro, M.D.

Pontificia Universidad Catolica de Chile

Related
1 trials

Shared therapeutic areas:

Acute Respiratory Tract Infections

Worked with same sponsors:

Laboratorio PasteurNational Fund for Research and Development in Health, Chile+1 more
Collaborated on 1 trial
Similarity Score14%

Carlos A. Camargo Jr., M.D. Dr.PH.

Massachusetts General Hospital, Harvard University

Related
1 trials

Shared therapeutic areas:

Acute Respiratory Tract Infections

Worked with same sponsors:

Laboratorio PasteurNational Fund for Research and Development in Health, Chile+1 more
Collaborated on 1 trial
Similarity Score14%

Diego García-Huidobro, M.D., Ph.D.

Pontificia Universidad Catolica de Chile

Related
1 trials

Shared therapeutic areas:

COVID-19

Worked with same sponsors:

Altum Pharmaceuticals INCPontificia Universidad Catolica de Chile
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04988217Phase 1/2StudyDirector

Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)

Coronavirus Disease 2019
Completed
NCT04186949StudyDirector

Early Origins of Allergy and Asthma

Allergic SensitisationAllergyAsthma+2 more
Completed
NCT02046577Phase 2StudyDirector

Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children

Acute Respiratory Tract Infections
Completed

All 3 trials loaded